Ligand Pharmaceuticals Incorporated
Net Cash Flow Breakdown
Total Cash from Operations: $114.4M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $0 | 0.0% |
| Business Acquisitions | $0 | 0.0% |
| Other Financing | $40.2M | 35.2% |
| Working Capital | $64.8M | 56.7% |
| Other | $9.3M | 8.2% |
| Net Cash Flow | $0 | 0.0% |